This approach to prostate diagnosis and care has significant benefits for clinical teams and patients, eliminating the randomness of standard TRUS prostate biopsies. Suspect areas detected by the MRI are thereby displayed on the ultrasound scanner, allowing the urologist to target the necessary biopsies.

Prostate fusion biopsy is a revolutionary technology made possible by overlaying ultrasound images of the prostate with MRI sequences for visualization and targeting of lesions.

Prior to its development, ultrasound probes were only used for guidance, as they are limited to organ contour imaging, not the tumor within. The use of MRI to detect prostate cancer represents the latest revolution in prostate cancer diagnosis. MRI/US transrectal fusion biopsyĪ precise diagnosis is essential to determine the best treatment pathway. Therefore, this substandard approach is characterized by an inadequate, uncertain diagnosis that contributes to overtreatment and undertreatment. The random nature of this method is such that the presence of significant cancers cannot be excluded. The 2D ultrasound image enables the urologist to navigate the prostate and spread out the biopsies (generally 12 biopsies, 6 per prostatic lobe) according to a sextant pattern in order to maximize their effectiveness.ġ2-core template for “blind” transrectal biopsies, left base not sampled (1) Transrectal Biopsy – Procedures “Blind” Transrectal Biopsy

Trinity Fusion download the new